| Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis | PeerJ |  | | 2021 | 377 | 176 |
|
| More evidence for dolutegravir as first-line ART for all | The Lancet HIV | | | 2020 | 202 | 42 |
|
| Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection | The Journal of Infectious Diseases | | | 2020 | 252 | 228 |
|
| All-Cause mortality and causes of death in the Swiss Hepatitis C Cohort Study (SCCS) | Open Forum Infectious Diseases | | | 2020 | 391 | 205 |
|
| Modelling the impact of different testing strategies for HCV infection in switzerland | Journal of virus eradication | | | 2019 | 437 | 136 |
|
| Vaccination anti-HPV: mise à jour 2019 pour la consultation | Swiss Medical Forum | | | 2019 | 460 | 482 |
|
| Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study | PLOS ONE | | | 2019 | 471 | 234 |
|
| Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk prediction | International Journal of Cancer | | | 2019 | 314 | 333 |
|
| Non-inferiority of simplified dolutegravir monotherapy compared to continued combination antiretroviral therapy that was initiated during primary HIV infection: a randomized, controlled, multi-site, open-label, non-inferiority trial | Clinical Infectious Diseases | | | 2019 | 412 | 215 |
|
| Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing? | Clinical Infectious Diseases | | | 2019 | 544 | 196 |
|
| Impact of Screening and Treatment for Hepatitis C Virus (HCV) Infection in Switzerland. A Comprehensive Mathematical Model of the Swiss HCV Epidemic | | | | 2018 | 612 | 208 |
|
| New-onset type 2 diabetes mellitus among patients receiving HIV care at Newlands Clinic, Harare, Zimbabwe: retrospective cohort analysis | Tropical Medicine & International Health | | | 2017 | 585 | 310 |
|
| Trends in hepatitis C-related mortality in Switzerland | Journal of Hepatology | | | 2017 | 1,258 | 894 |
|
| Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM | AIDS | | | 2017 | 596 | 457 |
|
| Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations | PloS one | | | 2016 | 638 | 580 |
|
| Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study | International journal of cancer | | | 2016 | 699 | 394 |
|
| Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period | HIV medicine |  | | 2016 | 516 | 0 |
|
| HIV-infected women in Europe: gender-specific needs and challenges | Antiviral therapy | | | 2013 | 638 | 0 |
|
| Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study | American journal of epidemiology | | | 2013 | 690 | 0 |
|
| Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery | Journal of acquired immune deficiency syndromes | | | 2013 | 765 | 0 |
|
| Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study | Antiviral therapy | | | 2007 | 628 | 0 |
|
